Global Digital Biomarker Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04250938

Publication Date:

April 17, 2025

Pages:

121

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Digital Biomarker market size is predicted to grow from US$ 1796 million in 2025 to US$ 73460 million in 2031; it is expected to grow at a CAGR of 85.6% from 2025 to 2031.
Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.
Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.
The 鈥淒igital Biomarker Industry Forecast鈥� looks at past sales and reviews total world Digital Biomarker sales in 2024, providing a comprehensive analysis by region and market sector of projected Digital Biomarker sales for 2025 through 2031. With Digital Biomarker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Biomarker industry.
This Insight Report provides a comprehensive analysis of the global Digital Biomarker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Biomarker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Digital Biomarker market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Biomarker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Biomarker.
This report presents a comprehensive overview, market shares, and growth opportunities of Digital Biomarker market by product type, application, key players and key regions and countries.
Segmentation by Type:
Passive Digital Biomarker
Active Digital Biomarker
Segmentation by Application:
Clinical Disease
Daily Health
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Apple
Sanofi
GlaxoSmithKline
Bayer
Merck
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Digital Biomarker Market Size (2020-2031)
2.1.2 Digital Biomarker Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Digital Biomarker by Country/Region (2020, 2024 & 2031)
2.2 Digital Biomarker Segment by Type
2.2.1 Passive Digital Biomarker
2.2.2 Active Digital Biomarker
2.3 Digital Biomarker Market Size by Type
2.3.1 Digital Biomarker Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Digital Biomarker Market Size Market Share by Type (2020-2025)
2.4 Digital Biomarker Segment by Application
2.4.1 Clinical Disease
2.4.2 Daily Health
2.5 Digital Biomarker Market Size by Application
2.5.1 Digital Biomarker Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Digital Biomarker Market Size Market Share by Application (2020-2025)
3 Digital Biomarker Market Size by Player
3.1 Digital Biomarker Market Size Market Share by Player
3.1.1 Global Digital Biomarker Revenue by Player (2020-2025)
3.1.2 Global Digital Biomarker Revenue Market Share by Player (2020-2025)
3.2 Global Digital Biomarker Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Digital Biomarker by Region
4.1 Digital Biomarker Market Size by Region (2020-2025)
4.2 Global Digital Biomarker Annual Revenue by Country/Region (2020-2025)
4.3 Americas Digital Biomarker Market Size Growth (2020-2025)
4.4 APAC Digital Biomarker Market Size Growth (2020-2025)
4.5 Europe Digital Biomarker Market Size Growth (2020-2025)
4.6 Middle East & Africa Digital Biomarker Market Size Growth (2020-2025)
5 Americas
5.1 Americas Digital Biomarker Market Size by Country (2020-2025)
5.2 Americas Digital Biomarker Market Size by Type (2020-2025)
5.3 Americas Digital Biomarker Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Digital Biomarker Market Size by Region (2020-2025)
6.2 APAC Digital Biomarker Market Size by Type (2020-2025)
6.3 APAC Digital Biomarker Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Digital Biomarker Market Size by Country (2020-2025)
7.2 Europe Digital Biomarker Market Size by Type (2020-2025)
7.3 Europe Digital Biomarker Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Digital Biomarker by Region (2020-2025)
8.2 Middle East & Africa Digital Biomarker Market Size by Type (2020-2025)
8.3 Middle East & Africa Digital Biomarker Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Digital Biomarker Market Forecast
10.1 Global Digital Biomarker Forecast by Region (2026-2031)
10.1.1 Global Digital Biomarker Forecast by Region (2026-2031)
10.1.2 Americas Digital Biomarker Forecast
10.1.3 APAC Digital Biomarker Forecast
10.1.4 Europe Digital Biomarker Forecast
10.1.5 Middle East & Africa Digital Biomarker Forecast
10.2 Americas Digital Biomarker Forecast by Country (2026-2031)
10.2.1 United States Market Digital Biomarker Forecast
10.2.2 Canada Market Digital Biomarker Forecast
10.2.3 Mexico Market Digital Biomarker Forecast
10.2.4 Brazil Market Digital Biomarker Forecast
10.3 APAC Digital Biomarker Forecast by Region (2026-2031)
10.3.1 China Digital Biomarker Market Forecast
10.3.2 Japan Market Digital Biomarker Forecast
10.3.3 Korea Market Digital Biomarker Forecast
10.3.4 Southeast Asia Market Digital Biomarker Forecast
10.3.5 India Market Digital Biomarker Forecast
10.3.6 Australia Market Digital Biomarker Forecast
10.4 Europe Digital Biomarker Forecast by Country (2026-2031)
10.4.1 Germany Market Digital Biomarker Forecast
10.4.2 France Market Digital Biomarker Forecast
10.4.3 UK Market Digital Biomarker Forecast
10.4.4 Italy Market Digital Biomarker Forecast
10.4.5 Russia Market Digital Biomarker Forecast
10.5 Middle East & Africa Digital Biomarker Forecast by Region (2026-2031)
10.5.1 Egypt Market Digital Biomarker Forecast
10.5.2 South Africa Market Digital Biomarker Forecast
10.5.3 Israel Market Digital Biomarker Forecast
10.5.4 Turkey Market Digital Biomarker Forecast
10.6 Global Digital Biomarker Forecast by Type (2026-2031)
10.7 Global Digital Biomarker Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Digital Biomarker Forecast
11 Key Players Analysis
11.1 Philips
11.1.1 Philips Company Information
11.1.2 Philips Digital Biomarker Product Offered
11.1.3 Philips Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Philips Main Business Overview
11.1.5 Philips Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Digital Biomarker Product Offered
11.2.3 Johnson & Johnson Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Digital Biomarker Product Offered
11.3.3 Pfizer Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Company Information
11.4.2 GE Healthcare Digital Biomarker Product Offered
11.4.3 GE Healthcare Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 GE Healthcare Main Business Overview
11.4.5 GE Healthcare Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Digital Biomarker Product Offered
11.5.3 Novartis Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Apple
11.6.1 Apple Company Information
11.6.2 Apple Digital Biomarker Product Offered
11.6.3 Apple Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Apple Main Business Overview
11.6.5 Apple Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Digital Biomarker Product Offered
11.7.3 Sanofi Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Digital Biomarker Product Offered
11.8.3 GlaxoSmithKline Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Digital Biomarker Product Offered
11.9.3 Bayer Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck Digital Biomarker Product Offered
11.10.3 Merck Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Merck Main Business Overview
11.10.5 Merck Latest Developments
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Information
11.11.2 Abbott Laboratories Digital Biomarker Product Offered
11.11.3 Abbott Laboratories Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Abbott Laboratories Main Business Overview
11.11.5 Abbott Laboratories Latest Developments
11.12 Asahi Kasei
11.12.1 Asahi Kasei Company Information
11.12.2 Asahi Kasei Digital Biomarker Product Offered
11.12.3 Asahi Kasei Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Asahi Kasei Main Business Overview
11.12.5 Asahi Kasei Latest Developments
11.13 Biogen
11.13.1 Biogen Company Information
11.13.2 Biogen Digital Biomarker Product Offered
11.13.3 Biogen Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Biogen Main Business Overview
11.13.5 Biogen Latest Developments
11.14 Koneksa Health
11.14.1 Koneksa Health Company Information
11.14.2 Koneksa Health Digital Biomarker Product Offered
11.14.3 Koneksa Health Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Koneksa Health Main Business Overview
11.14.5 Koneksa Health Latest Developments
11.15 Roche
11.15.1 Roche Company Information
11.15.2 Roche Digital Biomarker Product Offered
11.15.3 Roche Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Roche Main Business Overview
11.15.5 Roche Latest Developments
11.16 Huma Therapeutics
11.16.1 Huma Therapeutics Company Information
11.16.2 Huma Therapeutics Digital Biomarker Product Offered
11.16.3 Huma Therapeutics Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Huma Therapeutics Main Business Overview
11.16.5 Huma Therapeutics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂